Expert Review of Pharmacoeconomics & Outcomes Research, Volume 16, Issue 2 (2016)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Pharmacoeconomics & Outcomes Research, Volume 16, Issue 2 (2016)

See all volumes and issues
Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Volume 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Editorial

Editorial
Differences in utilization rates between commercial and administrative databases: implications for future health-economic and cross-national studies
Kristina Garuolienė, Brian Godman, Jolanta Gulbinovič, Krijn Schiffers & Björn Wettermark
Pages: 149-152
Published online: 17 Mar 2016
First Page PreviewforDifferences in utilization rates between commercial and administrative databases: implications for future health-economic and cross-national studies | Full Text | References | PDF (326.4 KB)
  • 1044 Views
  • 16 CrossRef citations
  • 0Altmetric
Free Access

Drug Profile

Article
Clinical and economic review of secukinumab for moderate-to-severe plaque psoriasis
Ian TY Wong, Kam Shojania, Jan Dutz & Nicole W Tsao
Pages: 153-166
Published online: 02 Feb 2016
AbstractforClinical and economic review of secukinumab for moderate-to-severe plaque psoriasis | Full Text | References | PDF (1.1 MB)
  • 913 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Economic evaluations of fluticasone-propionate/salmeterol combination therapy for chronic obstructive pulmonary disease: a review of published studies
M. H. Roberts, M. E. Borrego, A. A. Kharat, P. L. Marshik & D. W. Mapel
Pages: 167-192
Published online: 22 Feb 2016
AbstractforEconomic evaluations of fluticasone-propionate/salmeterol combination therapy for chronic obstructive pulmonary disease: a review of published studies | Full Text | References | PDF (2 MB)
  • 215 Views
  • 1 CrossRef citations
  • 0Altmetric

Special Report

Article
Continuous patient engagement in cardiovascular disease clinical comparative effectiveness research
Joseph Vandigo, Ebenezer Oloyede, Abdalla Aly, Aurelia L. Laird, Catherine E. Cooke & C. Daniel Mullins
Pages: 193-198
Published online: 25 Mar 2016
AbstractforContinuous patient engagement in cardiovascular disease clinical comparative effectiveness research | Full Text | References | PDF (544.1 KB)
  • 203 Views
  • 7 CrossRef citations
  • 0Altmetric
Article
Over-the-counter medicine and dietary supplement consumption among academic youth in Poland
Tomasz Bochenek, Brian Godman, Katarzyna Lipowska, Karolina Mikrut, Sandra Zuziak, Magdalena Pedzisz, Aneta Nowak & Andrzej Pilc
Pages: 199-205
Published online: 29 Feb 2016
AbstractforOver-the-counter medicine and dietary supplement consumption among academic youth in Poland | Full Text | References | PDF (618 KB) | Supplemental
  • 220 Views
  • 5 CrossRef citations
  • 0Altmetric

Perspective

Article
Is the EQ-5D suitable for use in oncology? An overview of the literature and recent developments
Matthias Schwenkglenks & Klazien Matter-Walstra
Pages: 207-219
Published online: 18 Feb 2016
AbstractforIs the EQ-5D suitable for use in oncology? An overview of the literature and recent developments | Full Text | References | PDF (995.8 KB)
  • 406 Views
  • 24 CrossRef citations
  • 0Altmetric

Review

Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for stroke prevention in non-valvular atrial fibrillation: a systematic and qualitative review
Nicola Lucio Liberato & Monia Marchetti
Pages: 221-235
Published online: 02 Mar 2016
AbstractforCost-effectiveness of non-vitamin K antagonist oral anticoagulants for stroke prevention in non-valvular atrial fibrillation: a systematic and qualitative review | Full Text | References | PDF (1.3 MB) | Supplemental
  • 632 Views
  • 13 CrossRef citations
  • 0Altmetric
Drug utilization and medication costs at the end of life
Lisa Pont, Kristian Jansen, Margrete Aase Schaufel, Dagny Faksvåg Haugen & Sabine Ruths
Pages: 237-243
Published online: 25 Mar 2016
AbstractforDrug utilization and medication costs at the end of life | Full Text | References | PDF (538.3 KB)
  • 224 Views
  • 3 CrossRef citations
  • 0Altmetric
Endocrine therapy for breast cancer prevention in high-risk women: clinical and economic considerations
Amy G. Groom & Tallal Younis
Pages: 245-255
Published online: 17 Mar 2016
AbstractforEndocrine therapy for breast cancer prevention in high-risk women: clinical and economic considerations | Full Text | References | PDF (792.5 KB)
  • 161 Views
  • 1 CrossRef citations
  • 0Altmetric
Budget impact analysis of medicines: updated systematic review and implications
Daniel Resende Faleiros, Juliana Álvares, Alessandra Maciel Almeida, Vânia Eloisa de Araújo, Eli Iola Gurgel Andrade, Brian B. Godman, Francisco A. Acurcio & Augusto A. Guerra Júnior
Pages: 257-266
Published online: 17 Mar 2016
AbstractforBudget impact analysis of medicines: updated systematic review and implications | Full Text | References | PDF (904.8 KB)
  • 473 Views
  • 30 CrossRef citations
  • 0Altmetric
Palliative care outcome measures in COPD patients: a conceptual review
Sabina Antonela Antoniu & Lucian Vasile Boiculese
Pages: 267-274
Published online: 25 Mar 2016
AbstractforPalliative care outcome measures in COPD patients: a conceptual review | Full Text | References | PDF (573 KB)
  • 386 Views
  • 2 CrossRef citations
  • 0Altmetric

Original Research

Article
Cost–effectiveness of treatments for high-risk myelodysplastic syndromes after failure of first-line hypomethylating agent therapy
Christopher R Cogle, Jesse D Ortendahl, Tanya GK Bentley, Ayanna M Anene, Scott Megaffin, Thomas J McKearn, Michael E Petrone & Sudipto Mukherjee
Pages: 275-284
Published online: 20 Nov 2015
AbstractforCost–effectiveness of treatments for high-risk myelodysplastic syndromes after failure of first-line hypomethylating agent therapy | Full Text | References | PDF (535.5 KB)
  • 175 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Cost–effectiveness analysis of simeprevir with daclatasvir for non-cirrhotic genotype-1b-naïve patients plus chronic hepatitis C
Vicente Gimeno-Ballester, Javier Mar & Ramón San Miguel
Pages: 285-294
Published online: 29 Aug 2015
AbstractforCost–effectiveness analysis of simeprevir with daclatasvir for non-cirrhotic genotype-1b-naïve patients plus chronic hepatitis C | Full Text | References | PDF (1.1 MB) | Supplemental
  • 249 Views
  • 11 CrossRef citations
  • 0Altmetric
Indirect costs of absenteeism due to rheumatoid arthritis, psoriasis, multiple sclerosis, insulin-dependent diabetes mellitus, and ulcerative colitis in 2012: a study based on real-life data from the Social Insurance Institution in Poland
Krzysztof Piotr Malinowski, Paweł Piotr Kawalec & Paweł Moćko
Pages: 295-303
Published online: 17 Sep 2015
AbstractforIndirect costs of absenteeism due to rheumatoid arthritis, psoriasis, multiple sclerosis, insulin-dependent diabetes mellitus, and ulcerative colitis in 2012: a study based on real-life data from the Social Insurance Institution in Poland | Full Text | References | PDF (1.2 MB)
  • 291 Views
  • 7 CrossRef citations
  • 0Altmetric
Article
The economic impact of symptomatic menopause among low-socioeconomic women in the United States
Allison Keshishian, Yuexi Wang, Lin Xie & Onur Baser
Pages: 305-313
Published online: 02 Aug 2015
AbstractforThe economic impact of symptomatic menopause among low-socioeconomic women in the United States | Full Text | References | PDF (834.9 KB)
  • 188 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
The cost of managing severe hypoglycemic episodes in Type 2 diabetic patients
Pedro Almeida Laires, João Conceição, Francisco Araújo, Jorge Dores, Catarina Silva, Larry Radican & Ana Nogueira
Pages: 315-325
Published online: 07 Sep 2015
AbstractforThe cost of managing severe hypoglycemic episodes in Type 2 diabetic patients | Full Text | References | PDF (1.1 MB) | Supplemental
  • 372 Views
  • 6 CrossRef citations
  • 0Altmetric

Explore articles